| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/07/2011 | WO2010138395A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 04/07/2011 | WO2010135491A3 Fibroblast growth factor mutants having improved functional half-life and methods of their use |
| 04/07/2011 | WO2010135459A3 Brain delivery of insulin to treat systemic inflammation |
| 04/07/2011 | WO2010132609A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 04/07/2011 | WO2010121352A8 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy |
| 04/07/2011 | WO2010097788A9 Visfatin therapeutic agents for the treatment of acne and other conditions |
| 04/07/2011 | WO2010088527A3 Peptides and nanoparticles for therapeutic and diagnostic applications |
| 04/07/2011 | WO2009133408A3 Protein formulation |
| 04/07/2011 | US20110083201 Compositions for and methods of grazyme b inhibition |
| 04/07/2011 | US20110082482 Materials and Methods for Nerve Repair |
| 04/07/2011 | US20110082287 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110082281 Casein hydrolyzate, process for producing the same and use thereof |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082154 Sigma ligands for neuronal regeneration and functional recovery |
| 04/07/2011 | US20110082096 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases |
| 04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 04/07/2011 | US20110082094 Mammalian Cytokine-Like Polypeptide-10 |
| 04/07/2011 | US20110082093 Methods and compositions for treating trinucleotide repeat disorders |
| 04/07/2011 | US20110082092 Interfering rna delivery system and uses thereof |
| 04/07/2011 | US20110082091 Method for Preclinical Testing of Immunomodulatory Drugs |
| 04/07/2011 | US20110082090 Compounds suited as nanocarriers for active agents and their use |
| 04/07/2011 | US20110082089 Biomarkers for monitoring or predicting the treatment of cancer |
| 04/07/2011 | US20110082088 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent |
| 04/07/2011 | US20110082087 Compounds for treating pain |
| 04/07/2011 | US20110082086 Medicament for use in connection with cartilage impairment |
| 04/07/2011 | US20110082085 Peptides derived from the c2 domain of epsilon pkc and methods of use, thereof |
| 04/07/2011 | US20110082084 Methods for the prevention or treatment of heart failure |
| 04/07/2011 | US20110082083 Formulations of liquid stable antithrombin |
| 04/07/2011 | US20110082082 Skin wound healing compositions and methods of use thereof |
| 04/07/2011 | US20110082081 Compositions and methods for repair of tissues |
| 04/07/2011 | US20110082080 Compositions and methods of using the human proislet peptide receptor |
| 04/07/2011 | US20110082079 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110082077 Sialic acid derivatives for protein derivatisation and conjugation |
| 04/07/2011 | US20110082076 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| 04/07/2011 | US20110082075 Anti-viral fusion peptides |
| 04/07/2011 | US20110082074 Agent for preventing periodontal disease |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110082072 Methods of Inhibiting Cell Death or Inflammation in a Mammal |
| 04/07/2011 | US20110082071 Delivery system for an active ingredient |
| 04/07/2011 | US20110082070 Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency |
| 04/07/2011 | US20110081730 Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic target |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081426 Aminothiazole modulators of beta-3-adrenoreceptor |
| 04/07/2011 | US20110081421 Methods of regulating renalase (monoamine oxidase c) |
| 04/07/2011 | US20110081418 Transdermal absorption enhancer |
| 04/07/2011 | US20110081417 Surgical compositions |
| 04/07/2011 | US20110081409 Selective inhibitors of histone deacetylase |
| 04/07/2011 | US20110081404 Novel liposome compositions |
| 04/07/2011 | US20110081403 Histone octamers for increased nucleic acid transfer |
| 04/07/2011 | US20110081402 Cosmetic base comprising collagen-modified liposome and skin cosmetic containing the same |
| 04/07/2011 | US20110081401 Dermal patch comprising chondrus crispus extract |
| 04/07/2011 | US20110081394 Methods of attaching a molecule-of-interest to a microtube |
| 04/07/2011 | US20110081381 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/07/2011 | US20110081370 Methods and Compositions for Modulating Immune Tolerance |
| 04/07/2011 | US20110081369 Immune modulation with death receptor-induced apoptosis |
| 04/07/2011 | US20110081362 Treatment of cancer |
| 04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 04/07/2011 | US20110081349 Allergenic latex protein |
| 04/07/2011 | US20110081348 Fungal signalling and metabolic enzymes |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081338 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation |
| 04/07/2011 | US20110081336 Processing biomass |
| 04/07/2011 | US20110081335 Processing biomass |
| 04/07/2011 | US20110081334 C1-Inhibitor Prevents Non-Specific Plasminogen Activation by a Prourokinase Mutant without Impeding Fibrin-Specific Fibrinolysis |
| 04/07/2011 | US20110081333 Apparatus and system for treatment and prevention of bags under eyes |
| 04/07/2011 | US20110081332 Treatment of non-alcoholic steatotic hepatitis (nash) |
| 04/07/2011 | US20110081331 Cancer therapy |
| 04/07/2011 | US20110081330 Compositions of fat-soluble active ingredients containing gum ghatti |
| 04/07/2011 | US20110081329 Amino acid compositions |
| 04/07/2011 | US20110081324 Collagen peptide conjugates and uses therefor |
| 04/07/2011 | US20110081323 Methods and compositions for organ and tissue functionality |
| 04/07/2011 | US20110081320 Treatment/Cure of Autoimmune Disease |
| 04/07/2011 | US20110081316 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 04/07/2011 | US20110081315 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 04/07/2011 | US20110081314 Antiviral phosphinate compounds |
| 04/07/2011 | US20110081313 Mechanism of action of primary cell derived biologic |
| 04/07/2011 | US20110081312 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 04/07/2011 | US20110081311 Complexes of il-15 and il-15ralpha and uses thereof |
| 04/07/2011 | US20110081293 Methods and compositions related to clot-binding lipid compounds |
| 04/07/2011 | US20110079528 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2011 | DE20321836U1 Hydroxyalkylstärkederivate Hydroxyalkylstärkederivate |
| 04/07/2011 | DE102008005097B4 Antitumoraler Cyclodepsipeptide, deren Herstellung und Verwendung Antitumoral cyclodepsipeptides, their preparation and use |
| 04/07/2011 | CA2776778A1 Peptides |
| 04/07/2011 | CA2776529A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | CA2776503A1 Compositions and methods for enhancing coagulation factor viii function |
| 04/07/2011 | CA2775846A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/06/2011 | EP2306187A1 Cancer eradication program |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305819A1 Conjugates prepared with aggregate-free proteins |
| 04/06/2011 | EP2305817A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
| 04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
| 04/06/2011 | EP2305798A2 Detection of mutations in a gene associated with resistance to viral infection, OAS1 |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305713A1 Human antibodies that bind human TNFalpha |
| 04/06/2011 | EP2305712A1 Human antibodies that bind human TNFalpha |